Health
Waystar shares slip in Nasdaq debut after digital health company priced IPO in middle of range
Waystar shares slid about 3% in their Nasdaq debut on Friday, after the health-care payment software vendor priced its IPO in the middle of the expected range. The stock opened at $21 per share, below the IPO price of $21.50 late Thursday. Waystar said its expected price would be between $20 and $23 per share […]
Read More
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! I’m back in New York City after spending the last weekend in […]
Read More
Weight loss drugs like Wegovy could spawn a host of new piggyback product lines
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images LONDON — The rapid rise of weight loss drugs like Wegovy is generating a host of new product lines as companies hope to land on the right side of the health care disruptor. Industries spanning food and beverage […]
Read More
Oscar Health CEO Mark Bertolini is ready to take on the employer market
Mark Bertolini has helped Oscar Health move toward profitability after taking over as CEO of the health insurer a year ago. Now, he says the company’s next phase of growth and profitability will focus on tapping into the employer market. That effort will include “going after the 71 million lives that are in small group […]
Read More
The FDA reverses its ban on Juul e-cigarettes
Juul packages are seen on a shelf at Empire Smoke Shop on December 07, 2022 in the Flatbush neighborhood of Brooklyn borough in New York City. Michael M. Santiago | Getty Images The Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated […]
Read More
Common sugar substitute linked to increased risk of heart attack and stroke
The safety of sugar substitutes is once again being called into question. Researchers led by the Cleveland Clinic linked the low-calorie sugar substitute xylitol to an increased risk of heart attack, stroke or cardiovascular-related deaths, according to a study published today in the European Heart Journal. Xylitol is a sugar alcohol that is found in […]
Read More
Scientists develop ultra-thin battery for smart contact lenses that could be charged by tears
Scientist Lee Seok Woo said a scene from a “Mission Impossible” movie inspired his latest invention: batteries for smart contact lenses. In the fourth film of the series, an agent wears contact lenses capable of facial recognition and eye tracking. Lee wanted to make that lens a reality. “I was thinking, ‘How can I work […]
Read More
Medical startup Sword Health announces AI that patients can talk to
Patient using Sword Health. Courtesy: Sword Health Pain management startup Sword Health on Tuesday announced a new artificial intelligence solution named Phoenix that patients can speak with for guidance through virtual physical therapy sessions. Sword, founded in 2015, offers digital tools to help patients manage pain from home and avoid other treatments like opioids and […]
Read More
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented as a stack of lawsuits relating to the discontinued heartburn drug Zantac move forward. […]
Read More
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. The vaccine together with Merck’s Keytruda improved survival and showed long-lasting efficacy in a midstage study in patients with a deadly form of skin cancer. […]
Read More